» Articles » PMID: 25990233

Haemagglutinin Mutations and Glycosylation Changes Shaped the 2012/13 Influenza A(H3N2) Epidemic, Houston, Texas

Overview
Journal Euro Surveill
Date 2015 May 21
PMID 25990233
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

While the early start and higher intensity of the 2012/13 influenza A virus (IAV) epidemic was not unprecedented, it was the first IAV epidemic season since the 2009 H1N1 influenza pandemic where the H3N2 subtype predominated. We directly sequenced the genomes of 154 H3N2 clinical specimens collected throughout the epidemic to better understand the evolution of H3N2 strains and to inform the H3N2 vaccine selection process. Phylogenetic analyses indicated that multiple co-circulating clades and continual antigenic drift in the haemagglutinin (HA) of clades 5, 3A, and 3C, with the evolution of a new 3C subgroup (3C-2012/13), were the driving causes of the epidemic. Drift variants contained HA substitutions and alterations in the potential N-linked glycosylation sites of HA. Antigenic analysis demonstrated that viruses in the emerging subclade 3C.3 and subgroup 3C-2012/13 were not well inhibited by antisera generated against the 3C.1 vaccine strains used for the 2012/13 (A/Victoria/361/2011) or 2013/14 (A/Texas/50/2012) seasons. Our data support updating the H3N2 vaccine strain to a clade 3C.2 or 3C.3-like strain or a subclade that has drifted further. They also underscore the challenges in vaccine strain selection, particularly regarding HA and neuraminidase substitutions derived during laboratory passage that may alter antigenic testing accuracy.

Citing Articles

Identification of H3N2 NA and PB1-F2 genetic variants and their association with disease symptoms during the 2014-15 influenza season.

Blumenkrantz D, Mehoke T, Shaw-Saliba K, Powell H, Wohlgemuth N, Liu H Virus Evol. 2021; 7(1):veab047.

PMID: 34131512 PMC: 8197029. DOI: 10.1093/ve/veab047.


Epidemic situation of the complex seasonality of imported influenza A and B virus transmission in Guangxi ports of China.

Li X, Liang Z, Gan J, Lu L Turk J Med Sci. 2020; 51(3):1021-1026.

PMID: 33237658 PMC: 8283440. DOI: 10.3906/sag-2008-63.


Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area.

Long S, Olsen R, Christensen P, Bernard D, Davis J, Shukla M mBio. 2020; 11(6).

PMID: 33127862 PMC: 7642679. DOI: 10.1128/mBio.02707-20.


Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area.

Long S, Olsen R, Christensen P, Bernard D, Davis J, Shukla M medRxiv. 2020; .

PMID: 33024977 PMC: 7536878. DOI: 10.1101/2020.09.22.20199125.


Large-Scale Complete-Genome Sequencing and Phylodynamic Analysis of Eastern Equine Encephalitis Virus Reveals Source-Sink Transmission Dynamics in the United States.

Tan Y, Lam T, Heberlein-Larson L, Smole S, Auguste A, Hennigan S J Virol. 2018; 92(12).

PMID: 29618651 PMC: 5974483. DOI: 10.1128/JVI.00074-18.


References
1.
Rambaut A, Pybus O, Nelson M, Viboud C, Taubenberger J, Holmes E . The genomic and epidemiological dynamics of human influenza A virus. Nature. 2008; 453(7195):615-9. PMC: 2441973. DOI: 10.1038/nature06945. View

2.
Wanzeck K, Boyd K, McCullers J . Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice. Am J Respir Crit Care Med. 2010; 183(6):767-73. PMC: 3159075. DOI: 10.1164/rccm.201007-1184OC. View

3.
Ampofo W, Busaidy S, Cox N, Giovanni M, Hay A, Huang S . Strengthening the influenza vaccine virus selection and development process: outcome of the 2nd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at the Centre International de Conférences (CICG) Geneva, Switzerland, 7.... Vaccine. 2013; 31(32):3209-21. DOI: 10.1016/j.vaccine.2013.05.049. View

4.
Dormitzer P, Suphaphiphat P, Gibson D, Wentworth D, Stockwell T, Algire M . Synthetic generation of influenza vaccine viruses for rapid response to pandemics. Sci Transl Med. 2013; 5(185):185ra68. DOI: 10.1126/scitranslmed.3006368. View

5.
Bragstad K, Emborg H, Fischer T, Voldstedlund M, Gubbels S, Andersen B . Low vaccine effectiveness against influenza A(H3N2) virus among elderly people in Denmark in 2012/13--a rapid epidemiological and virological assessment. Euro Surveill. 2013; 18(6). View